May 25, 2020

Reflexion – $100 Million

Date posted: 04/17/2020

Business location: Hayward, CA

Amount Funded: $100 Million

Type: Equity

Lead Investor: Public Sector Pension Investment Board

Participating Investor(s):  The Rise Fund, KCK Group, Sofinnova Partners, Venrock, T. Rowe Price, Pfizer Ventures, Johnson & Johnson Innovation, JJDC Inc.

Note:  Investors in red are new investors to this company.

Total Funding to Date: not listed

Company Description: “RefleXion is a privately-held company developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability to one day treat multiple tumors in the same treatment session in cancers that have metastasized. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT),  stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) imaging data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with subsecond latency.”

What funding will be used for:  Scale operation commercializing the X1 platform, validation of the practical implications on its cancer treatment for potential patients.

Media/information contact:

Amy Cook
acook@reflexion.com
925.200.2125

Data provided by respective company (unless otherwise noted) and researched by StartupsOne for accuracy. 

 

StartupsOne

StartupsOne features relevant, focused news on venture capital funding of technology oriented startup businesses based in North America.

View all posts by StartupsOne →